SCHEDULE OF WARRANT OUTSTANDING (Details) - $ / shares shares in Thousands		6 Months Ended		12 Months Ended
		Jun. 30, 2024		Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants outstanding, beginning balance		2,821
Warrant price, beginning balance	[1]	$ 13.15
Weighted average remaining contractual life, Ending	[2]	4 years 6 months		4 years 7 months 6 days
Number of stock options, options outstanding, exercised, shares	[3]	(1,394)
Number of stock options, options outstanding, forfeited, shares		(24)
Warrants outstanding, ending balance		9,149	[4]	2,821
Warrant price, ending balance	[1]	$ 2.96		$ 13.15
Warrants outstanding, exercisable ending balance	[5]	9,095
Warrant price, exercisable ending balance	[1]	$ 2.90
Weighted average remaining contractual life, exercisable ending	[2]	4 years 7 months 6 days
Private Placement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grants of warrants	[6]	6,271
Consultants for Services [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grants of warrants	[7]	4
Warrant Inducement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grants of warrants	[8]	1,471

[1] Represents the weighted average exercise price.

[2] Represents the weighted average remaining contractual term until the warrants expire.

[3] During the first quarter of 2024, the Company issued an aggregate of 1,393,393 shares of common stock from the exercise of warrants previously issued in November 2023.

[4] As of June 30, 2024, the aggregate intrinsic value of warrants outstanding was $0 million.

[5] As of June 30, 2024, the aggregate intrinsic value of warrants exercisable was $0 million.

[6] In June 30, 2024, the Company granted warrants in connection with a private placement consisting of warrants to purchase up to an aggregate of 3,220,266 shares of common stock at an exercise price of $2.204 per share, and pre-funded warrants to purchase up to an aggregate of 3,050,768 with a relative fair value of approximately $7.5 million which was recorded to additional paid-in capital at the time of issuance.

[7] During the second quarter of 2024, the Company granted warrants to purchase up to an aggregate of 4,000 shares of common stock at an exercise price of $2.38 per share, to consultant for business development services.

[8] In February 2024, the Company granted warrants in connection with a warrant inducement consisting of warrants to purchase up to an aggregate of 1,470,592 shares of common stock at an exercise price of $5.05 per share, with a relative fair value of approximately $3.9 million which was recorded to additional paid-in capital at the time of issuance.